-
公开(公告)号:US20120202763A1
公开(公告)日:2012-08-09
申请号:US13321257
申请日:2010-05-27
申请人: Neil Almstead , Tamil Arasu , Soongyu Choi , Liangxian Cao , Jeffrey Allen Campbelll , Donald Corson , Thomas W. Davis , Jason D. Graci , Zhengxian Gu , Peter Seong Woo Hwang , William Lennox , Harry H. Miao , Langdon Miller , Young-Choon Moon , Hongyan Qi , Christopher Trotta , Marla L. Weetall
发明人: Neil Almstead , Tamil Arasu , Soongyu Choi , Liangxian Cao , Jeffrey Allen Campbelll , Donald Corson , Thomas W. Davis , Jason D. Graci , Zhengxian Gu , Peter Seong Woo Hwang , William Lennox , Harry H. Miao , Langdon Miller , Young-Choon Moon , Hongyan Qi , Christopher Trotta , Marla L. Weetall
IPC分类号: A61K31/437 , A61K31/496 , A61K31/5377 , A61K31/506 , A61K31/541 , A61K31/53 , A61K31/497 , A61P35/00 , A61P31/12 , A61P19/02 , A61P37/00 , A61P3/04 , A61P17/06 , A61P9/10 , A61P27/02 , A61P27/06 , A61P27/14 , A61P3/02 , A61P29/00 , A61P11/00 , A61P13/12 , A61P9/12 , A61P17/02 , A61P1/04 , A61P31/22 , A61P33/02 , A61P17/12 , A61P9/00 , A61P7/06 , A61P19/04 , A61P31/04 , A61P27/10 , A61P31/14 , A61P31/16 , A61P31/20 , A61P31/18 , C12N5/09 , C12N5/071 , C07H19/056 , A61K31/7056 , C07F7/10 , A61K31/695 , A61P17/10 , C07D471/04
CPC分类号: C07D471/04 , A61K31/437 , A61K31/44 , A61K31/4745 , A61K45/06 , Y02A50/385 , Y02A50/387 , Y02A50/393 , Y02A50/401 , Y02A50/463 , Y02A50/465
摘要: Compounds that selectively inhibit pathological production of human vascular endothelial growth factor (VEGF) and compositions comprising such Compounds are described. Compounds that inhibit viral replication or the production of viral RNA or DNA or viral protein and compositions comprising such Compounds are described. Also described are methods of reducing VEGF using such Compounds and methods for treating cancer and non-neoplastic conditions involving the administration of such Compounds. Further described are methods of inhibiting viral replication or the production of viral RNA or DNA or viral protein using such Compounds and methods for treating viral infections involving the administration of such Compounds. The Compounds may be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatments.
摘要翻译: 描述了选择性抑制人血管内皮生长因子(VEGF)的病理生成的化合物和包含这些化合物的组合物。 描述了抑制病毒复制或产生病毒RNA或DNA或病毒蛋白的化合物和包含这些化合物的组合物。 还描述了使用这些化合物还原VEGF的方法以及用于治疗涉及施用这些化合物的癌症和非肿瘤性病症的方法。 进一步描述的是使用这种用于治疗涉及施用这些化合物的病毒感染的化合物和方法来抑制病毒复制或产生病毒RNA或DNA或病毒蛋白质的方法。 化合物可以作为单一药物治疗或与一种或多种另外的治疗组合施用于需要这种治疗的人。
-
公开(公告)号:US09351964B2
公开(公告)日:2016-05-31
申请号:US13321257
申请日:2010-05-27
申请人: Neil Almstead , Tamil Arasu , Soongyu Choi , Liangxian Cao , Jeffrey Allen Campbell , Donald Corson , Thomas W. Davis , Jason D. Graci , Zhengxian Gu , Peter Seongwoo Hwang , William Lennox , Harry H. Miao , Langdon Miller , Young-Choon Moon , Hongyan Qi , Christopher Trotta , Marla L. Weetall
发明人: Neil Almstead , Tamil Arasu , Soongyu Choi , Liangxian Cao , Jeffrey Allen Campbell , Donald Corson , Thomas W. Davis , Jason D. Graci , Zhengxian Gu , Peter Seongwoo Hwang , William Lennox , Harry H. Miao , Langdon Miller , Young-Choon Moon , Hongyan Qi , Christopher Trotta , Marla L. Weetall
IPC分类号: A01N43/04 , A61K31/44 , A61K45/06 , A61K31/4745 , A61K31/437 , C07D471/04
CPC分类号: C07D471/04 , A61K31/437 , A61K31/44 , A61K31/4745 , A61K45/06 , Y02A50/385 , Y02A50/387 , Y02A50/393 , Y02A50/401 , Y02A50/463 , Y02A50/465
摘要: Compounds, such as compounds of Formula (I), that selectively inhibit pathological production of human vascular endothelial growth factor (VEGF) and compositions comprising such Compounds are described. Compounds that inhibit viral replication or the production of viral RNA or DNA or viral protein and compositions comprising such Compounds are described. Also described are methods of reducing VEGF using such Compounds and methods for treating cancer and non-neoplastic conditions involving the administration of such Compounds. Further described are methods of inhibiting viral replication or the production of viral RNA or DNA or viral protein using such Compounds and methods for treating viral infections involving the administration of such Compounds. The Compounds may be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatments.
摘要翻译: 描述了选择性抑制人血管内皮生长因子(VEGF)的病理生成的化合物,例如式(I)的化合物和包含这些化合物的组合物。 描述了抑制病毒复制或产生病毒RNA或DNA或病毒蛋白的化合物和包含这些化合物的组合物。 还描述了使用这些化合物还原VEGF的方法以及用于治疗涉及施用这些化合物的癌症和非肿瘤性病症的方法。 进一步描述的是使用这种用于治疗涉及施用这些化合物的病毒感染的化合物和方法来抑制病毒复制或产生病毒RNA或DNA或病毒蛋白质的方法。 化合物可以作为单一药物治疗或与一种或多种另外的治疗组合施用于需要这种治疗的人。
-
公开(公告)号:US20130171103A1
公开(公告)日:2013-07-04
申请号:US13699849
申请日:2011-05-26
申请人: Thomas Davis , Jason D. Graci , Zhengxian Gu , Christopher Trotta
发明人: Thomas Davis , Jason D. Graci , Zhengxian Gu , Christopher Trotta
IPC分类号: C07D471/04 , A61K45/06 , A61K31/4545 , A61K38/21 , A61K31/7056 , A61K39/29 , A61K39/42 , A61K31/7088 , A61K31/437 , A61K31/5377
CPC分类号: C07D471/04 , A61K31/40 , A61K31/437 , A61K31/4545 , A61K31/5377 , A61K31/7056 , A61K31/7088 , A61K38/21 , A61K39/29 , A61K39/42 , A61K45/06 , Y02A50/385 , Y02A50/387 , Y02A50/393 , Y02A50/463 , Y02A50/465
摘要: Compounds that selectively inhibit viral replication or the production of viral RNA or DNA, viral protein or virus induced cytopathic effects and compositions comprising such Compounds are described. Also described are methods of inhibiting viral replication or the production of viral RNA or DNA, viral protein or virus induced cytopathic effects using such Compounds and methods for treating viral infections involving the administration of such Compounds. The Compounds may be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatments.
摘要翻译: 描述了选择性抑制病毒复制或产生病毒RNA或DNA,病毒蛋白或病毒诱导的细胞病变效应的化合物和包含这些化合物的组合物。 还描述了使用这些化合物和用于治疗涉及施用这些化合物的病毒感染的方法来抑制病毒复制或产生病毒RNA或DNA,病毒蛋白或病毒诱导的细胞病变效应的方法。 化合物可以作为单一药物治疗或与一种或多种另外的治疗组合施用于需要这种治疗的人。
-
-